257 related articles for article (PubMed ID: 10678830)
1. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.
Rudolph KL; Chang S; Millard M; Schreiber-Agus N; DePinho RA
Science; 2000 Feb; 287(5456):1253-8. PubMed ID: 10678830
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral delivery of truncated MMP-8 fused with the hepatocyte growth factor mutant 1K1 ameliorates liver cirrhosis and promotes hepatocyte proliferation.
Liu J; Li J; Fu W; Tang J; Feng X; Chen J; Liang Y; Jin R; Xie A; Cai X
Drug Des Devel Ther; 2015; 9():5655-67. PubMed ID: 26527860
[TBL] [Abstract][Full Text] [Related]
3. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability.
Hemann MT; Strong MA; Hao LY; Greider CW
Cell; 2001 Oct; 107(1):67-77. PubMed ID: 11595186
[TBL] [Abstract][Full Text] [Related]
4. Biomedicine. New genetic tricks to rejuvenate ailing livers.
Hagmann M
Science; 2000 Feb; 287(5456):1185, 1187. PubMed ID: 10712144
[No Abstract] [Full Text] [Related]
5. Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis.
Sato R; Maesawa C; Fujisawa K; Wada K; Oikawa K; Takikawa Y; Suzuki K; Oikawa H; Ishikawa K; Masuda T
Gut; 2004 Jul; 53(7):1001-9. PubMed ID: 15194652
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage.
Wiemann SU; Satyanarayana A; Buer J; Kamino K; Manns MP; Rudolph KL
Oncogene; 2005 Feb; 24(9):1501-9. PubMed ID: 15608677
[TBL] [Abstract][Full Text] [Related]
7. Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion.
Garcia-Bañuelos J; Siller-Lopez F; Miranda A; Aguilar LK; Aguilar-Cordova E; Armendariz-Borunda J
Gene Ther; 2002 Jan; 9(2):127-34. PubMed ID: 11857071
[TBL] [Abstract][Full Text] [Related]
8. Impaired germinal center reaction in mice with short telomeres.
Herrera E; Martínez-A C; Blasco MA
EMBO J; 2000 Feb; 19(3):472-81. PubMed ID: 10654945
[TBL] [Abstract][Full Text] [Related]
9. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres.
Herrera E; Samper E; Martín-Caballero J; Flores JM; Lee HW; Blasco MA
EMBO J; 1999 Jun; 18(11):2950-60. PubMed ID: 10357808
[TBL] [Abstract][Full Text] [Related]
10. Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
Donaires FS; Scatena NF; Alves-Paiva RM; Podlevsky JD; Logeswaran D; Santana BA; Teixeira AC; Chen JJ; Calado RT; Martinelli ALC
PLoS One; 2017; 12(8):e0183287. PubMed ID: 28813500
[TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency of mTR results in defects in telomere elongation.
Hathcock KS; Hemann MT; Opperman KK; Strong MA; Greider CW; Hodes RJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3591-6. PubMed ID: 11904421
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Bojovic B; Crowe DL
Mol Carcinog; 2013 Feb; 52(2):103-17. PubMed ID: 22086874
[TBL] [Abstract][Full Text] [Related]
13. Telomerase therapeutics for degenerative diseases.
Harley CB
Curr Mol Med; 2005 Mar; 5(2):205-11. PubMed ID: 15974874
[TBL] [Abstract][Full Text] [Related]
14. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
Farazi PA; Glickman J; Horner J; Depinho RA
Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
[TBL] [Abstract][Full Text] [Related]
15. Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress.
Alves-Paiva RM; Kajigaya S; Feng X; Chen J; Desierto M; Wong S; Townsley DM; Donaires FS; Bertola A; Gao B; Young NS; Calado RT
Liver Int; 2018 Jan; 38(1):144-154. PubMed ID: 28741793
[TBL] [Abstract][Full Text] [Related]
16. Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis.
de Oliveira SA; de Freitas Souza BS; Sá Barreto EP; Kaneto CM; Neto HA; Azevedo CM; Guimarães ET; de Freitas LA; Ribeiro-Dos-Santos R; Soares MB
Cytotherapy; 2012 Mar; 14(3):339-49. PubMed ID: 22149185
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial gene therapy renders increased survival in cirrhotic rats.
Gálvez-Gastélum FJ; Segura-Flores AA; Senties-Gomez MD; Muñoz-Valle JF; Armendáriz-Borunda JS
J Biomed Sci; 2010 May; 17(1):42. PubMed ID: 20509929
[TBL] [Abstract][Full Text] [Related]
18. Telomere and telomerase in chronic liver disease and hepatocarcinoma.
Carulli L; Anzivino C
World J Gastroenterol; 2014 May; 20(20):6287-92. PubMed ID: 24876749
[TBL] [Abstract][Full Text] [Related]
19. A possible role for telomerase RNA and telomere length in global mitotic recombination.
Bouffler SD; Finnon P; Blasco MA; Ainsbury E
Cytogenet Genome Res; 2008; 122(3-4):292-6. PubMed ID: 19188698
[TBL] [Abstract][Full Text] [Related]
20. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy.
Ozawa S; Uchiyama K; Nakamori M; Ueda K; Iwahashi M; Ueno H; Muragaki Y; Ooshima A; Yamaue H
Surgery; 2006 Apr; 139(4):563-73. PubMed ID: 16627068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
